Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Fetal cells could improve skin repair with minimal scarring and are a potential ready-to-use solution for tissue engineering.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Mutations in the HEPHL1 gene cause abnormal hair and cognitive issues.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Scientists created keratinocyte cell lines from human hair that can differentiate similarly to normal skin cells, offering a new way to study skin biology and diseases.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

iPSCs help understand and treat neurodevelopmental disorders.

Rice bran oil extracted by supercritical CO2 is considered non-genotoxic.

A genetic duplication on chromosome 5 was linked to a woman's unique combination of medical conditions.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

A rare EGFR mutation in newborns leads to severe health issues and early death.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Early treatment of acne is crucial to prevent scarring and psychological effects.